Dr. Gerhard Schaefer
Dr Gerhard Schaefer did his doctorate in Organic Chemistry at the University of Stuttgart in 1981. After gaining initial professional experience in managerial roles in pharmaceutical development, quality assurance and quality control, he held further management positions in business development with renowned companies such as Azupharma, Knoll, Stada, HEXAL and Sandoz. From 2003, Dr Schaefer served on the Board of Directors of HEXAL AG, and after the acquisition of HEXAL AG by Novartis/Sandoz in 2005 was appointed Managing Director at Sandoz International and Head of Global Product Development and Global Business Development. From 2005 to 2012, Dr Schaefer managed 11 development centres. Since 2013, Dr Schaefer has worked freelance as an advisory board member and consultant for portfolio selection and product development for pharmaceutical companies in Germany, France and Poland.